期刊文献+

甲状腺乳头状癌颈后三角淋巴结隐匿转移的临床分析 被引量:14

Clinical analysis of level V occult metastasis of papillary thyroid carcinoma
原文传递
导出
摘要 目的分析甲状腺乳头状癌颈后三角(V区)淋巴结隐匿转移的发生情况。方法回顾性分析中国医学科学院肿瘤医院头颈外科475例V区临床阴性的初治甲状腺乳头状癌患者的临床资料,统计其中275例临床颈部淋巴结阳性(cN+)患者颈清扫标本的病理资料,并按甲状腺乳头状癌危险度分为高危组(83例)、中危组(104例)和低危组(88例),分析V区淋巴结转移情况;另对200例临床无淋巴结转移(oN0)患者进行随访,记录其颈部复发情况。结果275例cN+患者的V区淋巴结隐匿转移率为17.5%,其中低、中、高危组分别为9.1%、19.2%和24.1%,(P〈0.05)。按颈静脉链淋巴结(Ⅱ~Ⅳ区)阳性数目分为1枚、2~10枚和〉10枚组,其V区隐匿转移率分别为0、4.5%和24.6%。结论甲状腺乳头状癌颈转移的患者如临床未发现V区有肿大淋巴结,需结合患者情况慎重决定是否清扫V区,低危患者和其他区域淋巴结转移较少者可考虑密切观察。 Objective To analyze the occurrence and frequency of level V occult metastasis of papillary thyroid carcinoma. Methods The clinlcopathological data of 475 patients in our hospital from 1980 to 1996 were retrospectively analyzed. Pathological results of 275 cN + patients were analyzed and 200 cases with no lymph node metastasis were followed up to compare the recurrence rate of those two groups. The 275 cN + patients were divided into 3 subgroups according to the risk levels: high risk group 83 cases, moderate risk group 104 cases and low risk group 88 cases. Results The occurrence rate of level V node occult metastasis in the 275 cases was 17.5% , among them, the results of low risk, moderate and high risk groups were 9. 1% , 19.2% and 24. 1% , respectively (Chi-Square value 7. 041, P 〈 0.05). These 3 groups were divided according to the number of level Ⅱ -Ⅳ positive lymph nodes 1 , 2-10 and more than 10, and the rate was 0, 4.5% and 24.6% , respectively. Conclusion Careful prudence is needed to decide whether a patient of papillary thyroid carcinoma with clinically negative level V node nletastasis should be operated for level V lymph node dissection or not. Patients of low risk group or with less positive lymph nodes could be kept under observation for level V node metastasis.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第4期313-315,共3页 Chinese Journal of Oncology
关键词 甲状腺肿瘤 淋巴转移 颈淋巴结清扫术 Thyroid neoplasms Lymphatic metastasis Neck dissection
  • 相关文献

参考文献11

  • 1边学,徐震纲,张彬,刘文胜,毛传远,唐平章.分化型甲状腺癌的颈淋巴转移规律[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):599-602. 被引量:67
  • 2Kupferman ME,Weinstock YE,Santillan AA,et al.Predictors of level Ⅴ metastasis in well-differentiated thyroid cancer.Head Neck,2008,30:1469-1474. 被引量:1
  • 3Wada N,Dun QY,Sugino K,et al.Lymph node metastasis from 259 papillary thyroid microcarcinomas:frequency,pattern of occurrence and recurrence,and optimal strategy for neck dissection.Ann Surg,2003,237:399-407. 被引量:1
  • 4屠规益主编..现代头颈肿瘤外科学[M].北京:科学出版社,2004:994.
  • 5Orlov S,Orlov D,Shaytzag M,et al.Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma.Head Neck,2009,31:782-789. 被引量:1
  • 6Mazzaferri EL,Young RL.Papillary thyroid carcinoma:a 10 year follow-up report of the impact of therapy in 576 patients.Am J Med,1981,70:511-518. 被引量:1
  • 7殷玉林,徐震纲,唐平章,李进让,边学.甲状腺乳头状癌颈部的处理[J].中华肿瘤杂志,2000,22(4):321-323. 被引量:60
  • 8张仑,李树玲.1 173例甲状腺乳头状癌外科治疗远期疗效观察[J].中国肿瘤临床,2003,30(11):805-808. 被引量:59
  • 9Pingpank JF,Sasson AR,Hanlon AL,et al.Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes.Arch Otolaryngol Head Neck Surg,2002,128:1275-1278. 被引量:1
  • 10Ito Y,Higashiyama T,Takamura Y,et al.Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis:validity of prophylactic modified radical neck dissection.World J Surg,2007,31:2085-2091. 被引量:1

二级参考文献20

  • 1刘文胜,唐平章,汪晓春,殷玉林.甲状腺乳头状癌颈部淋巴结转移的临床分析[J].癌症进展,2004,2(4):238-242. 被引量:42
  • 2牛丽娟,郝玉芝,周纯武.超声诊断甲状腺占位性病变的价值[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):415-418. 被引量:117
  • 3罗德红,中华肿瘤杂志,1998年,20卷,48页 被引量:1
  • 4刘经祖,实用外科杂志,1988年,8卷,435页 被引量:1
  • 5李树玲,国外医学.肿瘤学分册,1984年,4卷,193页 被引量:1
  • 6Mazzaferri EL,Massoll N.Management of papillary and follicular (differentiated) thyroid cancer:new paradigms using recombinant human thyrotropin.Endocr Relat Cancer,2002,9:227-247. 被引量:1
  • 7Kinder BK.Well differentiated thyroid cancer.Curr Opin Oncol,2003,15:71-77. 被引量:1
  • 8Simon D,Goretzki PE,Witte J,et al.Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.World J Surg,1996,20:860-866. 被引量:1
  • 9Mirallie E,Visset J,Sagan C,et al.Localization of cervical node metastasis of papillary thyroid carcinoma.World J Surg,1999,23:970-974. 被引量:1
  • 10Noguchi M,Kumaki T,Taniya T,et al.Bilateral cervical lymph node metastases in well-differentiated thyroid cancer.Arch Surg,1990,125:804-806. 被引量:1

共引文献172

同被引文献142

  • 1孙建光,胡浩忠,戴亚伟,陶国卫,张芸.cN_0甲状腺乳头状癌74例治疗分析[J].中国癌症杂志,2011,21(4):294-297. 被引量:13
  • 2赏金标,王可敬,张海,刘爱华,郭良,葛明华.甲状腺乳头状癌再次手术临床分析[J].中华普通外科杂志,2005,20(2):123-123. 被引量:19
  • 3李树玲.我国甲状腺癌外科现状与展望[J].临床外科杂志,2006,14(3):129-130. 被引量:46
  • 4边学,徐震纲,张彬,刘文胜,毛传远,唐平章.分化型甲状腺癌的颈淋巴转移规律[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):599-602. 被引量:67
  • 5Kupferman ME, Weinstock YE, Santillan AA, et al. Predictors of level V metastasis in well-differentiated thyroid cancer. Head Neck ,2008,30 : 1469-1474. 被引量:1
  • 6Deschler DG, Day T. Pocket guide to neck dissection classification and TNM staging of head and neck cancer. Alexandria: American Academy of Otolaryngology-I-Iead and Neck Surgery Foundation. Inc ,1991:9-20. 被引量:1
  • 7Gonztlez HE, Cruz F, O' Brien A, et al. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg,2007,133:1258-1262. 被引量:1
  • 8Roh JL, Park JY, Kim JM, et al. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Onco1,2009 ,99 :28-31. 被引量:1
  • 9Sebastian SO, Gonzalez JM, Paricio PP, et al. Papillary thyroid carcinoma:prognostic index for survival including the histological variety. Arch Surg,2000,135:272-277. 被引量:1
  • 10Gardner RE,Tuttle RM, Burman KD, et al. Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg, 2000,126 : 309 -312. 被引量:1

引证文献14

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部